title: The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
authors: Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
authors: Ameet
authors: A
authors: Sarpatwari
authors: Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
authors: Aaron S
authors: AS
authors: Kesselheim
mesh_terms: D003365:Costs and Cost Analysis; D016527:Drug Costs; D004345:Drug Industry / Q000379:methods*; D016568:Drugs, Generic; D004465:Economic Competition; D006801:Humans; D010330:Patents as Topic / Q000706:statistics & numerical data*
chemical_list: D016568:Drugs, Generic